SFDA Product Classification: Choose the Correct Route
Unsure about SFDA product classification? Learn how formula, intended use, dosage form and claims determine the correct Saudi regulatory route.
8/31/20267 min read
SFDA Product Classification: Choose the Correct Regulatory Route
Reviewed by: Saudi Food Registration Regulatory Team – Product Classification & SFDA Compliance
A product described as a food, supplement or wellness product in another country may not automatically follow the same regulatory route in Saudi Arabia.
SFDA product classification considers the complete product profile: its composition, ingredient levels, intended use, claims, dosage form, instructions, presentation and target consumer.
Getting this assessment wrong can affect much more than the category selected in an application. It can lead companies to prepare the wrong label, collect unsuitable documents, use the wrong submission system or commission testing that does not support the applicable route.
Classification should therefore be confirmed before the company finalizes its Saudi label, regulatory file or launch plan.
What Is SFDA Product Classification?
SFDA product classification determines which regulatory scope and pathway are applicable to a product in Saudi Arabia.
For products near the boundaries between regulatory sectors, the assessment may need to establish whether the product belongs within:
The food sector
A herbal or health-product pathway
The cosmetics sector
The drug sector
The medical-device sector
Another regulated or non-regulated scope
Commercial descriptions do not decide this outcome.
Calling a product a “functional drink,” “natural supplement,” “beauty powder” or “wellness gummy” does not establish its Saudi classification. The authority considers what the product contains, how it is used and what the company communicates about it.
The same ingredient may also be treated differently depending on its concentration, form, recommended intake, combination with other substances and intended purpose.
Why Classification Must Come Before Registration
Classification determines the regulatory foundation of the project.
The selected route can affect:
The responsible regulatory sector
The electronic submission system
Applicant and establishment requirements
Formula documentation
Label and artwork requirements
Permitted claims
Technical evidence
Testing expectations
Certificates and manufacturer documents
Approval and post-market obligations
If classification changes after the label and dossier have been prepared, several parts of the file may need to be rebuilt.
For example, removing one problematic claim may not resolve the issue if the formula, dosage form and directions still support another regulatory interpretation.
The objective is not simply to choose the fastest route. It is to establish the most defensible route for the product that will actually be marketed.
What Determines a Product’s SFDA Classification?
No individual factor should be assessed in isolation. The complete product profile must present one consistent regulatory identity.
1. Intended Purpose
The first question is what the product is designed and presented to do.
A product intended for ordinary nutrition is different from one promoted to modify a physiological function, address a health condition or produce a therapeutic effect.
The assessment should consider:
The stated purpose
Directions for use
Marketing positioning
Website and advertising language
Target consumer
Expected pattern of consumption
Warnings and precautions
A neutral name on the label will not necessarily overcome therapeutic or disease-related positioning elsewhere in the product materials.
2. Formula and Ingredient Levels
The complete quantitative formula is essential, particularly for fortified, botanical, concentrated or multi-ingredient products.
The review should identify:
Every active and inactive ingredient
Ingredient quantities per serving and daily intake
Compound ingredients
Extract ratios and standardization
Vitamin and mineral levels
Additives and their functions
Ingredient restrictions
Interactions between composition and intended use
A familiar food ingredient does not automatically make the finished product a conventional food. Concentration, extraction, dosage and presentation can change the regulatory assessment.
3. Claims and Overall Presentation
Claims are a major classification signal, but they are not evaluated separately from the product.
The review should cover:
Product name
Front-of-pack wording
Nutrition and health claims
Functional claims
Disease-related language
Before-and-after representations
Consumer testimonials
Images and symbols
Website descriptions
Social-media and advertising content
Language suggesting treatment, prevention, diagnosis or control of a disease creates significant classification risk.
Replacing a prohibited word with softer marketing language is not sufficient if the overall presentation continues to communicate the same therapeutic purpose.
For a closer examination of this issue, see our guide to SFDA functional claims.
4. Dosage Form and Instructions
Capsules, tablets, gummies, drops, sachets, powders, beverages, oils and sprays can appear in several regulatory categories.
Format alone does not determine classification. However, it can affect how the product is understood when combined with:
Measured doses
Frequency of use
Maximum daily intake
Concentrated ingredients
Short treatment-style use periods
Medical-style warnings
Pharmaceutical presentation
A powder consumed freely as part of an ordinary diet may present a different regulatory profile from a concentrated powder supplied in measured daily doses with strong physiological claims.
5. Target Consumer
Products intended for infants, young children, pregnant consumers, patients or people with specific health conditions may require a different level of assessment.
The classification review should consider whether the product is:
Intended for the general population
Directed at a vulnerable group
Presented for use under professional supervision
Intended to meet a specific nutritional need
Marketed in connection with a medical condition
The intended consumer must remain consistent across the formula, label, instructions and supporting evidence.
6. Regulatory History
Approvals obtained in other countries can provide useful background, but they do not automatically determine the Saudi route.
Reviewers may examine:
Classification decisions from other authorities
Certificates of free sale
Existing product registrations
Approved labels
Manufacturer declarations
Previous SFDA correspondence
Earlier Saudi applications or queries
International status should be presented accurately as supporting context—not as proof that SFDA must adopt the same classification.
Products Most Likely to Create Classification Uncertainty
Classification questions frequently arise when a product combines characteristics associated with more than one regulatory pathway.
Examples include:
Fortified beverages with aggressive functional claims
Gummies containing concentrated vitamins, minerals or botanicals
Herbal extracts supplied in measured doses
Powders marketed for weight management or sports performance
Beauty products intended to be consumed orally
Products positioned around sleep, mood, cognition or hormonal effects
Concentrated drops, oils or sprays
Foods making disease-related claims
Products using ingredients associated with pharmaceutical use
Multi-ingredient products whose combined purpose is unclear
These products are not automatically prohibited or assigned to one category. They require closer assessment because the formula, intended purpose and presentation may point in different directions.
A Practical SFDA Classification Process
Step 1: Build the Complete Product Profile
Classification should not be attempted using the front label alone.
Prepare:
Full quantitative formula
Ingredient specifications
Proposed product name
Intended use
Recommended intake
Target consumer
Dosage form
Draft label
Complete claims list
Website or marketing descriptions
Manufacturer and country-of-origin information
Existing international classifications
Missing formula quantities or incomplete claims can lead to an assessment based on assumptions rather than the final commercial product.
Step 2: Identify Borderline Signals
Review whether any element points outside the expected food route.
Warning signals may include:
Therapeutic or disease-related claims
Highly concentrated ingredients
Pharmaceutical dosage forms
Unusual recommended intake
Ingredients with different regulatory uses
Medical-style instructions
Conflicting certificates or product descriptions
Different positioning across the label and marketing materials
The purpose is to identify uncertainty before the company invests in unsuitable artwork, documents or testing.
Step 3: Map the Likely Regulatory Route
Assess the product against the requirements associated with the possible routes.
This comparison should determine:
Which route best fits the complete product
Which evidence supports that conclusion
Which elements create uncertainty
Whether the formula or claims should be reconsidered
Which registration requirements would follow
The route should be supported by regulatory reasoning, not chosen because it appears less expensive or more convenient.
Step 4: Use an SFDA Classification Request When Necessary
Where the applicable scope remains uncertain, an official SFDA classification request may be appropriate.
The submission should accurately represent the final product. Changing material elements after receiving a classification outcome may affect whether that outcome remains relevant.
Companies should avoid submitting an incomplete version designed only to obtain a preferred result. If the final formula, claims, dosage or intended use differ materially, the product may require reassessment.
Step 5: Align the Complete Registration File
After the route is established, the complete submission should support it.
Check that the following communicate the same regulatory identity:
Formula
Product specification
Label
Claims
Instructions
Certificates
Testing plan
Manufacturer documents
Portal information
Commercial presentation
Classification is not complete if the application selects one pathway while the packaging and marketing imply another.
Can Changing the Label Resolve a Classification Problem?
Sometimes—but not always.
A claim or presentation change may reduce classification risk when the product’s formula and intended use already support the proposed route.
However, editing the label may not be sufficient when the concern comes from:
Ingredient concentration
Pharmacological characteristics
Dosage form
Recommended daily intake
Target consumer
Intended physiological effect
The product’s combined formulation
The formula and commercial strategy may need to be reviewed together.
This is particularly important for complex formulations. See our guide to multi-ingredient product registration.
What Happens If the Product Is Misclassified?
The consequences depend on when the issue is identified and how significantly the selected route differs from the product’s actual profile.
Possible effects include:
A request for clarification
Transfer or redirection to another regulatory pathway
New establishment or applicant requirements
Revised label and claims
Additional technical documents
Different testing or evidence
Rebuilding parts of the dossier
Reconsidering the formula or product positioning
Withdrawal and resubmission under the appropriate route
Delayed production, launch or shipment planning
Correct classification does not guarantee approval or a specific review time. It reduces the risk of building the application around an unsuitable regulatory foundation.
How Saudi Food Registration Can Help
Our regulatory team helps manufacturers, brand owners and Saudi importers establish the appropriate product route before submission.
Support may include:
Preliminary SFDA product classification assessment
Formula and ingredient review
Dosage and intended-use assessment
Claims and marketing review
Borderline-product analysis
Regulatory-route comparison
Classification-request preparation
Formula, label and dossier alignment
Food-supplement registration planning
Response support when classification is questioned
The objective is to give the product one clear, evidence-supported regulatory identity before artwork, documentation and registration work proceed.
Frequently Asked Questions
Is a Food Supplement Always Registered as a Food Product?
Not automatically. The applicable route depends on the complete formula, ingredient levels, claims, dosage form, intended use and presentation.
For product-specific planning, read our food supplement registration guide.
Does the Product’s Classification Abroad Apply in Saudi Arabia?
No. A foreign classification can provide useful supporting context, but SFDA applies the requirements and regulatory boundaries relevant to Saudi Arabia.
Does a Capsule or Tablet Automatically Become a Drug?
No. Dosage form is one factor among several. Composition, intended use, claims, intake and overall presentation must be assessed together.
Can We Finalize the Label Before Classification?
This is not recommended for a borderline product. Classification can affect the permitted claims, mandatory information, warnings, supporting evidence and applicable registration route.
Does an SFDA Classification Decision Guarantee Registration?
No. Classification identifies the applicable regulatory scope or route. The product must still meet the corresponding registration, safety, quality, labeling and documentation requirements.
Confirm the Route Before Building the Application
The costliest classification problems are usually discovered after the company has printed packaging, commissioned testing or prepared a dossier for the wrong route.
A structured review of the final formula, intended use, dosage, claims and presentation allows the regulatory strategy to be established while the product can still be adjusted.
Unsure which SFDA pathway applies to your product?
Contact our regulatory team or use the chatbot to request an initial product-classification and registration-route assessment.
Recommended Reads:
Learn how to fix SFDA registration rejection issues before they impact your timeline.
Explore proactive steps to prevent costly SFDA delays in your product launch.
See how multi-ingredient products can still meet SFDA approval with smart strategy.
Learn why SFDA product testing is the first step to avoid delays in our latest guide.
One often-missed requirement that can silently delay your approval is covered in The Hidden SFDA Compliance Step That Delays Product Approvals.